CytoSorbents Corp. (CTSO)
0.341
+0.01
(+1.61%)
USD |
NASDAQ |
Aug 31, 16:00
0.337
0.00 (0.00%)
After-Hours: 20:00
CytoSorbents Cash from Investing (Quarterly) : 0.007M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.007M |
| March 31, 2026 | -0.046M |
| December 31, 2025 | -0.291M |
| September 30, 2025 | 0.055M |
| June 30, 2025 | -0.1318M |
| March 31, 2025 | -0.0472M |
| December 31, 2024 | -0.1242M |
| September 30, 2024 | -0.299M |
| June 30, 2024 | -0.119M |
| March 31, 2024 | -0.127M |
| December 31, 2023 | -0.1359M |
| September 30, 2023 | -0.2577M |
| June 30, 2023 | 0.1403M |
| March 31, 2023 | -0.6829M |
| December 31, 2022 | -0.2061M |
| September 30, 2022 | -0.7165M |
| June 30, 2022 | -4.685M |
| March 31, 2022 | -0.848M |
| December 31, 2021 | -1.673M |
| September 30, 2021 | -1.018M |
| June 30, 2021 | -0.9847M |
| March 31, 2021 | -0.6063M |
| December 31, 2020 | -0.2661M |
| September 30, 2020 | -0.4042M |
| June 30, 2020 | -0.4974M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.5086M |
| December 31, 2019 | -0.4032M |
| September 30, 2019 | -0.3154M |
| June 30, 2019 | -0.3273M |
| March 31, 2019 | -0.4742M |
| December 31, 2018 | -0.3234M |
| September 30, 2018 | -0.2762M |
| June 30, 2018 | -0.4484M |
| March 31, 2018 | -0.4723M |
| December 31, 2017 | -0.582M |
| September 30, 2017 | -0.5392M |
| June 30, 2017 | -0.3525M |
| March 31, 2017 | -0.2045M |
| December 31, 2016 | -0.0982M |
| September 30, 2016 | 0.0624M |
| June 30, 2016 | 2.037M |
| March 31, 2016 | -0.4049M |
| December 31, 2015 | -0.4682M |
| September 30, 2015 | 1.059M |
| June 30, 2015 | -0.3468M |
| March 31, 2015 | -1.135M |
| December 31, 2014 | 5.214M |
| September 30, 2014 | -2.665M |
| June 30, 2014 | -0.0906M |
| March 31, 2014 | -4.771M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -673.00M |
| AngioDynamics, Inc. | -1.27M |
| Alphatec Holdings, Inc. | -22.72M |
| AtriCure, Inc. | -3.766M |
| Baxter International, Inc. | -117.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.583M |
| Free Cash Flow | -9.583M |
| Free Cash Flow Per Share (Quarterly) | -0.0101 |
| Free Cash Flow to Equity (Quarterly) | -1.075M |
| Free Cash Flow to Firm (Quarterly) | 0.233M |
| Free Cash Flow Yield | -44.77% |